AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

M7T Mach7 Technologies Limited

Healthcare · Health Information Services · website
$0.29
52wk 0.24 – 0.69
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Mach7 Technologies Limited

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor-agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. The company also provides workflow applications, such as a universal worklist, quality control (QC) tools designed for technologists' workflows; image sharing and exchange capabilities; teleradiology services; and additional specialized tools to serve departmental patient care needs. Mach7 Technologies Limited was founded in 2007 and is headquartered in South Burlington, Vermont.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$69.33M
P/E (trailing)
P/E (forward)
-10.35
EPS (trailing)
-0.04
Dividend yield
Payout ratio
0.0%
Beta
0.97
EV / EBITDA
-4.12
Price / Book
1.78
ROE
-22.1%
Operating margin
-41.7%
Net margin
-33.9%
Total cash
$18.49M
Total debt
$986,466
Current ratio
2.15
Debt / Equity
0.03
Free cash flow
$1.23M
Avg volume
219,525
Latest annual results (FY ending 30 Jun 2024)
  • Revenue$17.24M
  • Gross profit$15.80M
  • Operating income-$22.34M
  • Net income-$7.97M
  • Diluted EPS-0.03
  • Free cash flow$3.06M
  • Net debt-$24.91M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9